An MRI milestone was reached in mid-December when Toshiba America Medical Systems shipped its 300th Opart MRI scanner. The superconducting open system with a field strength of 0.35 tesla entered the market some three years ago. It was designed
An MRI milestone was reached in mid-December when Toshiba America Medical Systems shipped its 300th Opart MRI scanner. The superconducting open system with a field strength of 0.35 tesla entered the market some three years ago. It was designed specifically for the U.S. marketplace, where most have been sold. Ironically, the 300th unit was delivered to Toshiba Medical Systems Europe, which will install the product at a site in Italy.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.